Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-26

FDA Approved: TRIKAFTA — Original Application (Vertex Pharmaceuticals Incorporated)

View source ↗

Summary

The FDA approved TRIKAFTA (elexacaftor/tezacaftor/ivacaftor) as an original application for cystic fibrosis, representing a pivotal triple-combination therapy f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIKAFTA (ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR)

Snippet

ORIG AP for TRIKAFTA (ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR)